Epstein Secrets

Mercer Inc. (M&MC) USA International Trade Union Belgium Confederation (ITUC) OC Oerlikon Management AG Switzerland Suddeutsche Zeitung GmbH Medtronic Inc. Brevan Howard Investment Products Ltd Bekaert NV/SA Gamesa Corporacien Tecnologica SA Climate Change Capital Nature KPMG SWIFT SCRL Merck 8

Secretary-General Chief Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Development Managing Direc

ornia (USC) Charles H. Dallara Managing Director Institute of International USA Finance (IIF) James Dallas Senior Vice-President, Quality and Medtronic Inc. USA Operations John Dalli Commissioner, Health and Consumer Policy, European Commission, Brussels Luke J. Daly Founder and Chief Executive Of

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G

ornia (USC) Charles H. Dallara Managing Director Institute of International USA Finance (IIF) James Dallas Senior Vice-President, Quality and Medtronic Inc. USA Operations John Dalli Commissioner, Health and Consumer Policy, European Commission, Brussels Luke J. Daly Founder and Chief Executive Of

and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and G

Manufacture Co. Ltd illycaffe SpA Japan Airlines Co. Ltd Babson College Japan External Trade Organization (JETRO) Global Environment Facility Medtronic Inc. Third Point LLC Channel 4 News Keizai Doyukai (Japan Association of Corporate Executives) Massachusetts Institute of Technology (MIT) Profess

iness School Google Inc. USA USA Germany Switzerland USA USA World Economic Forum Annual Meeting EFTA_R1_02105175 EFTA02707407 President, Merck Vaccines MSD USA Julie Louise Gerberding Mikhail Gerchuk Mohammad Abdullah Al Gergawi David R. Gergen Valery Gergiev Natalia Germanova Ola

ure that allowed consumers to create their own personalized health plans. Stephen Oesterle, M.D., Senior Vice President for Medicine and Technology, Medtronic Inc. Dr. Oesterle is focused on the formation of technological strategies and continued development of relationships with the world’s medical communities.

) and Tioga. He was previously on the boards of Intarcia Therapuetics (now currently a Board observer), Sirna Therapeutics (NASDAQ: RNAI, acquired by Merck in 2006 for $1.1 billion), where he served as Chairman; Oriel Therapeutics (acquired by Novartis in 2010), where he served as Executive Chairman, and